ImmuCell CorporationICCCNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P14
Within normal range
vs 5Y Ago
-1.2x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -21.97% |
| 2024 | -11.29% |
| 2023 | -2.21% |
| 2022 | 7.81% |
| 2021 | -4.26% |
| 2020 | 18.06% |
| 2019 | 4.86% |
| 2018 | 71.81% |
| 2017 | 64.51% |
| 2016 | 0.73% |